Methodology for the Development of Clinical Practice Guideline for Chinese Patent Medicine（Part 1）： Development Status and Characteristics
- VernacularTitle:中成药临床实践指南制定方法（一）
- Author:
Ning LIANG
1
;
Lijiao YAN
1
;
Yujing ZHANG
1
;
Fuqiang ZHANG
1
;
Ziteng HU
1
;
Yaxin CHEN
1
;
Huizhen LI
1
;
Haili ZHANG
1
;
Zhao CHEN
1
;
Yin JIANG
1
;
Bin LIU
1
;
Nannan SHI
1
;
Yanping WANG
1
Author Information
- Publication Type:Journal Article
- Keywords: clinical practice guidelines; Chinese patent medicine; method for development of guideline; rational drug use
- From: Journal of Traditional Chinese Medicine 2024;65(1):44-49
- CountryChina
- Language:Chinese
- Abstract: The irrational use of Chinese patent medicines （CPM） is becoming more and more prominent， which makes the demand for clinical practice guidelines of CPM gradually increase. In order to make domestic scholars understand the latest developments and existing problems of the CPM guidelines， and promote its development， this paper introduced the concept of CPM guidelines， summarized the characteristics of the two development modes， namely “taking CPM as the key” and “taking disease/syndrome as the key”， and analyzed the current methodological status of developing and reporting CPM guidelines. Based on the existed problems， three suggestions have been put forward to optimize the quality of CPM guidelines， which were clarifying the target users and scope of CPM guidelines， establishing an open and transparent mechanism of the personnel involvement and process steps， and formulating implementable and operable recommendations for the use of CPM.
